Company Plans to Initiate First-in-Human Phase 1/2 Trial in 1H 2026, Anchored by a Leading U.S. Academic Medical Center. MIAMI, FL / ACCESS Newswire / April 30, 2026 / Telomir Pharmaceuticals, Inc.
The company is building the clinical intelligence and intervention layer to deliver whole-person cancer care at scale. NEW YORK CITY, NY / ACCESS Newswire / April 30, 2026 / Greatly Health, a ...
STOCKHOLM, SE / ACCESS Newswire / April 30, 2026 / Egetis Therapeutics (STO:EGTX) - Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (NASDAQ Stockholm:EGTX), today announced its participation ...
Global 3D Cell Culture Market OverviewThe global 3D cell culture market is poised for significant expansion, with projections ...
As diabetes continues to affect millions across Europe, the region’s healthcare sector is rapidly shifting towards solutions that improve disease management and patient outcomes. Among the most ...
Creative Biogene, a frontrunner in biotechnology solutions, providing cost-effective consumables and reagents, focusing on first generation as well as next-generation sequencing and DNA fragment ...
Ad hoc announcement pursuant to Art. 53 LR. Pratteln, Switzerland, April 30, 2026 – Santhera Pharmaceuticals (SIX: SANN) ...
The global hearing aids market is projected to grow at a rate of 6–7% over the next five years. This growth is driven by ...
The global obesity drugs market is projected to grow at a robust compound annual growth rate (CAGR) of approximately 25% ...
MALMÖ, SE / ACCESS Newswire / April 30, 2026 / Ascelia Pharma (STO:ACE):During April, the registered number of shares and votes in Ascelia Pharma AB ("Ascelia Pharma") has increased due to the ...
GOTHENBURG, SE / ACCESS Newswire / April 30, 2026 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments ...
Grants support discovery and development of novel drug candidates and evaluation and prioritization of advanced drug regimens for clinical testingNew funding from the Gates Foundation extends Evotec's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results